Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Blocking Nitrosylation Induces Immunogenic Cell Death by Sensitizing NRAS-Mutant Melanoma to MEK Inhibitors

Jyoti Srivastava, Vipin K. Yadav, Rachel V. Jimenez, Pravin R. Phadatare, Ninad A. Inamdar, Montana M. Young, Antonella Bacchiocchi, Ruth Halaban, Bin Fang, Alvaro de Mingo. Pulido, Kenneth Y. Tsai, Keiran S.M. Smalley, John M. Koomen, Paulo C. Rodriguez, Sanjay Premi

Cancer Res (2025)

https://doi.org/10.1158/0008-5472.CAN-24-0693

Published: 27 April 2025

View articletitled, Blocking Nitrosylation Induces Immunogenic Cell Death by Sensitizing NRAS-Mutant Melanoma to MEK Inhibitors

Includes: Supplementary data

Journal Articles

Abstract 153: High-resolution profiling of the tumor microenvironment with spatial ecotypes

Cancer Res (2025) 85 (8_Supplement_1): 153.

https://doi.org/10.1158/1538-7445.AM2025-153

Published: 21 April 2025

View articletitled, Abstract 153: High-resolution profiling of the tumor microenvironment with spatial ecotypes

Journal Articles

Abstract 1167: Prospective analysis of pretreatment circulating CD4 memory T cell features associated with severe immunotherapy toxicity

Abul Usmani, Noah Earland, Wubing Zhang, Peter K. Harris, Antonietta Bacchiocchi, Chloe M. Sachs, Aishwarya Nene, David Y. Chen, Mario Sznol, Ruth Halaban, Aaron M. Newman, Aadel A. Chaudhuri

Cancer Res (2024) 84 (6_Supplement): 1167.

https://doi.org/10.1158/1538-7445.AM2024-1167

Published: 22 March 2024

View articletitled, Abstract 1167: Prospective analysis of pretreatment circulating CD4 memory T cell features associated with severe immunotherapy toxicity

Journal Articles

Abstract 4745: A novel combination therapy targeting RAF, MEK and FAK to overcome skin cutaneous melanoma treatment resistance

Simone Lubrano, Farhoud Faraji, Rodolfo Daniel Cervantes-Villagrana, Sydney Ramirez, Nadia Arang, Adam Officer, Damiano C. Rigiracciolo, Paola Y. Anguiano Quiroz, Antonieta Bacchiocchi, Ruth Halaban, Silvia Coma, Sheri Holmen, Claudia Martini, Jonathan Pachter, Andrew Aplin, J. Silvio Gutkind

Cancer Res (2024) 84 (6_Supplement): 4745.

https://doi.org/10.1158/1538-7445.AM2024-4745

Published: 22 March 2024

View articletitled, Abstract 4745: A novel combination therapy targeting RAF, MEK and FAK to overcome skin cutaneous melanoma treatment resistance

Journal Articles

Abstract 6670: Association between circulating CD4 memory T cell levels and severe immune-related adverse events in melanoma patients treated with immune checkpoint blockade

Abul Usmani, Noah Earland, Wubing Zhang, Peter K. Harris, Antonietta Bacchiocchi, Aishwarya Nene, David Y. Chen, Mario Sznol, Ruth Halaban, Aaron M. Newman, Aadel A. Chaudhuri

Cancer Res (2023) 83 (7_Supplement): 6670.

https://doi.org/10.1158/1538-7445.AM2023-6670

Published: 04 April 2023

View articletitled, Abstract 6670: Association between circulating CD4 memory T cell levels and severe immune-related adverse events in melanoma patients treated with immune checkpoint blockade

Journal Articles

Abstract 1179: Rational combinations with the dual RAF/MEK inhibitor VS-6766 for treatment of cutaneous melanoma harboring BRAF, NRAS, NF1 or CRAF mutations

Antonella Bacchiocchi, Silvia Coma, Sanjib Chowdhury, Mario Sznol, Ruth Halaban, Jonathan A. Pachter

Cancer Res (2022) 82 (12_Supplement): 1179.

https://doi.org/10.1158/1538-7445.AM2022-1179

Published: 15 June 2022

View articletitled, Abstract 1179: Rational combinations with the dual RAF/MEK inhibitor VS-6766 for treatment of cutaneous melanoma harboring BRAF, NRAS, NF1 or CRAF mutations

Journal Articles

Abstract LB-104: Excited electrons in melanin induce cyclobutane dimers in the dark

Sanjay Premi, Silvia Wallisch, Camila Mano, Adam Weiner, Antonella Bacchiocchi, Kazumasa Wakamatsu, Etelvino Bechara, Ruth Halaban, Thierry Douki, Douglas E. Brash

Cancer Res (2015) 75 (15_Supplement): LB-104.

https://doi.org/10.1158/1538-7445.AM2015-LB-104

Published: 01 August 2015

View articletitled, Abstract LB-104: Excited electrons in melanin induce cyclobutane dimers in the dark

Journal Articles

PDK1 and SGK3 Contribute to the Growth of BRAF-Mutant Melanomas and Are Potential Therapeutic Targets

Marzia Scortegagna, Eric Lau, Tongwu Zhang, Yongmei Feng, Chris Sereduk, Hongwei Yin, Surya K. De, Katrina Meeth, James T. Platt, Casey G. Langdon, Ruth Halaban, Maurizio Pellecchia, Michael A. Davies, Kevin Brown, David F. Stern, Marcus Bosenberg, Ze'ev A. Ronai

Cancer Res (2015) 75 (7): 1399–1412.

https://doi.org/10.1158/0008-5472.CAN-14-2785

Published: 31 March 2015

View articletitled, PDK1 and SGK3 Contribute to the Growth of BRAF-Mutant Melanomas and Are Potential Therapeutic Targets

Includes: Supplementary data

Journal Articles

Identification of a melanoma prognostic model using tissue microarrays and genetic algorithms

Bonnie Gould Rothberg, Aaron Berger, Annette Molinaro, Antonio Subtil, Michael Krauthammer, William Bradley, Stephan Ariyan, Ruth Halaban, Harriet Kluger, David Rimm

Cancer Res (2008) 68 (9_Supplement): 5566.

Published: 01 May 2008

View articletitled, Identification of a melanoma prognostic model using tissue microarrays and genetic algorithms

Journal Articles

Quantitative multiplexed analysis of primary malignant melanoma defines a set of protein biomarkers that stratify patients by outcome within Breslow groups

Aaron J. Berger, Melissa Cregger, Michael Krauthammer, Kyle Divito, Gretchen Graff, Stephen Ariyan, Harriet Kluger, Ruth Halaban, Robert L. Camp, David L. Rimm

Cancer Res (2006) 66 (8_Supplement): 273.

Published: 15 April 2006

View articletitled, Quantitative multiplexed analysis of primary malignant melanoma defines a set of protein biomarkers that stratify patients by outcome within Breslow groups

Journal Articles

Automated Quantitative Analysis of HDM2 Expression in Malignant Melanoma Shows Association with Early-Stage Disease and Improved Outcome

Aaron J. Berger, Robert L. Camp, Kyle A. DiVito, Harriet M. Kluger, Ruth Halaban, David L. Rimm

Cancer Res (2004) 64 (23): 8767–8772.

https://doi.org/10.1158/0008-5472.CAN-04-1384

Published: 01 December 2004

View articletitled, Automated Quantitative Analysis of HDM2 Expression in Malignant Melanoma Shows Association with Early-Stage Disease and Improved Outcome

Journal Articles

Expression Profiling Reveals Novel Pathways in the Transformation of Melanocytes to Melanomas

Keith Hoek, David L. Rimm, Kenneth R. Williams, Hongyu Zhao, Stephan Ariyan, Aiping Lin, Harriet M. Kluger, Aaron J. Berger, Elaine Cheng, E. Sergio Trombetta, Terence Wu, Michio Niinobe, Kazuaki Yoshikawa, Gregory E. Hannigan, Ruth Halaban

Cancer Res (2004) 64 (15): 5270–5282.

https://doi.org/10.1158/0008-5472.CAN-04-0731

Published: 02 August 2004

View articletitled, Expression Profiling Reveals Novel Pathways in the Transformation of Melanocytes to Melanomas

Includes: Supplementary data

Journal Articles

Subcellular Localization of Activating Transcription Factor 2 in Melanoma Specimens Predicts Patient Survival

Aaron J. Berger, Harriet M. Kluger, Ning Li, Eric Kielhorn, Ruth Halaban, Ze’ev Ronai, David L. Rimm

Cancer Res (2003) 63 (23): 8103–8107.

Published: 16 December 2003

View articletitled, Subcellular Localization of Activating Transcription Factor 2 in Melanoma Specimens Predicts Patient Survival

Journal Articles

The Tyrphostin AG1024 Accelerates the Degradation of Phosphorylated Forms of Retinoblastoma Protein (pRb) and Restores pRb Tumor Suppressive Function in Melanoma Cells

Maria von Willebrand, Eldad Zacksenhaus, Elaine Cheng, Peter Glazer, Ruth Halaban

Cancer Res (2003) 63 (6): 1420–1429.

Published: 15 March 2003

View articletitled, The Tyrphostin AG1024 Accelerates the Degradation of Phosphorylated Forms of Retinoblastoma Protein (pRb) and Restores pRb Tumor Suppressive Function in Melanoma Cells

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Blocking Nitrosylation Induces Immunogenic Cell Death by Sensitizing NRAS-Mutant Melanoma to MEK Inhibitors

Abstract 153: High-resolution profiling of the tumor microenvironment with spatial ecotypes

Abstract 1167: Prospective analysis of pretreatment circulating CD4 memory T cell features associated with severe immunotherapy toxicity

Abstract 4745: A novel combination therapy targeting RAF, MEK and FAK to overcome skin cutaneous melanoma treatment resistance

Abstract 6670: Association between circulating CD4 memory T cell levels and severe immune-related adverse events in melanoma patients treated with immune checkpoint blockade

Abstract 1179: Rational combinations with the dual RAF/MEK inhibitor VS-6766 for treatment of cutaneous melanoma harboring BRAF, NRAS, NF1 or CRAF mutations

Abstract LB-104: Excited electrons in melanin induce cyclobutane dimers in the dark

PDK1 and SGK3 Contribute to the Growth of BRAF-Mutant Melanomas and Are Potential Therapeutic Targets

Identification of a melanoma prognostic model using tissue microarrays and genetic algorithms

Quantitative multiplexed analysis of primary malignant melanoma defines a set of protein biomarkers that stratify patients by outcome within Breslow groups

Automated Quantitative Analysis of HDM2 Expression in Malignant Melanoma Shows Association with Early-Stage Disease and Improved Outcome

Expression Profiling Reveals Novel Pathways in the Transformation of Melanocytes to Melanomas

Subcellular Localization of Activating Transcription Factor 2 in Melanoma Specimens Predicts Patient Survival

The Tyrphostin AG1024 Accelerates the Degradation of Phosphorylated Forms of Retinoblastoma Protein (pRb) and Restores pRb Tumor Suppressive Function in Melanoma Cells

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only